You are here

recessive dystrophic epidermolysis bullosa

5 Cell and Gene Therapy Decisions to Watch in 2024

BioSpace

Mon, 04/22/24 - 11:38 am

Abeona Therapeutics

recessive dystrophic epidermolysis bullosa

Rocket Pharmaceuticals

Leukocyte adhesion deficiency-1

advanced synovial sarcoma

Autolus Therapeutics

B cell acute lymphoblastic leukemia

FDA puts the brakes on a rare disease biotech’s PhIII as regulators wait for an update — shares crumble

Endpoints

Mon, 09/23/19 - 10:41 am

Abeona Therapeutics

clinical trials

recessive dystrophic epidermolysis bullosa